Haoxi Health Technology (HAO) Current Deferred Revenue (2023 - 2025)

Haoxi Health Technology's Current Deferred Revenue history runs 3 years deep, the most recent figure standing at $1.2 million for Q4 2025.

• On a quarterly basis, Current Deferred Revenue rose 68.96% year-over-year to $1.2 million in Q4 2025; TTM through Dec 2025 was $1.2 million, a 68.96% increase from a year earlier, with the FY2025 full-year figure at $537646.0, down 54.63% from the prior year.
• Current Deferred Revenue grew to $1.2 million in Q4 2025 per HAO's latest filing, from $537646.0 in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $1.5 million in Q2 2023 and bottomed at $537646.0 in Q2 2025.
• The 3-year median for Current Deferred Revenue is $1.2 million (2024), against an average of $1.0 million.
• Biggest YoY gain for Current Deferred Revenue was 68.96% in 2025; the steepest drop was 54.63% in 2025.
• Year by year, Current Deferred Revenue stood at $1.5 million in 2023, then tumbled by 51.5% to $724551.0 in 2024, then soared by 68.96% to $1.2 million in 2025.
• Per Business Quant, the three latest HAO Current Deferred Revenue figures stand at $1.2 million (Q4 2025), $537646.0 (Q2 2025), and $724551.0 (Q4 2024).